Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome
- PMID: 21411081
- DOI: 10.1016/j.fertnstert.2011.02.032
Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome
Abstract
The aim of this retrospective study is to investigate the frequency and severity of ovarian hyperstimulation syndrome and the pregnancy rate in a patient collective at risk who received bromocriptine treatment.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Comment in
-
Prevention of ovarian hyperstimulation syndrome.Fertil Steril. 2011 Jun 30;95(8):e65; author reply e66. doi: 10.1016/j.fertnstert.2011.04.017. Epub 2011 Apr 29. Fertil Steril. 2011. PMID: 21530962 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources